IOVANCE BIOTHERAPEUTICS, INC. (IOVA) Net Margin
- 2026-06-30: Net Margin -47.64%.
- 2026-03-31: Net Margin -110.66%.
- 2025-12-31: Net Margin -82.87%.
- 2025-09-30: Net Margin -135.28%.
Complete source-backed net margin history.
- Available history
- 2023-06-30 to 2026-06-30
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2026-06-30 | -47.64% |
| 2026-03-31 | -110.66% |
| 2025-12-31 | -82.87% |
| 2025-09-30 | -135.28% |
| 2025-06-30 | -186.25% |
| 2025-03-31 | -235.51% |
| 2024-12-31 | -106.60% |
| 2024-09-30 | -142.67% |
| 2024-06-30 | -312.16% |
| 2024-03-31 | -15800.84% |
| 2023-12-31 | -24145.02% |
| 2023-09-30 | -24255.86% |
| 2023-06-30 | -44759.66% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2025-12-31 | -148.38% |
| 2024-12-31 | -226.84% |
| 2023-12-31 | -37345.42% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |